A stool management system having a tubular body including a first end section disposable in a rectum of a patient and a second end section including a first connector which detachably mates with a second connector coupled to a collection container which receives waste matter passed through the tubular body from the bowel of the patient.

A closestool type urine and excrement detection robot and an Internet-of Things system thereof. The closestool type urine and excrement detection robot comprises: an intelligent moving module (15), an interaction system module (32), a height adjustment module (19), a user identity identification module (28), a closestool structure module (13), a urine gross recognition detection module (11), an odor detection module (25, 33), a urine component detection module (51), an excrement gross recognition detection module (14), an excrement component detection module (108), a cleaning flushing module, a waste treatment module (21), a wireless communication module (30), a central data processing module (24), a data security module, a battery and charging module (20), and a device maintenance module. The urine and excrement detection robot can automatically reach a preset position, provide urination and defecation behavioral monitoring and urine and excrement component detection for a user, and screen urinary and digestive system diseases as soon as possible; device maintenance, data processing, and medical support are provided by means of an Internet of Things system, and the Internet of Things system can also be used in cooperation with a squatting pan or a pedestal pan of the user; a closestool structure is customized according to the individuation of the user, and therefore, efficient, convenient and intelligent urine and excrement detection experience is provided for the user.

A collection device for a biological sample to capture target compounds such as viruses or other pathogens or particles for testing from within the sample and move the captured target compound to a separate chamber for subsequent processing. The collection device can include an openable substance blister including capture particles located in a cup interior. Capture particles can attract and bind the target compounds from the sample. An extraction tube extracts any nucleic acid from the target compound for storage or subsequent amplification and testing to confirm presence of known microorganisms. The extraction tube can comprise a heat-deformable material and can be connected to a microfluidic cartridge for further processing of nucleic acid including, amplification and detection. The microfluidic cartridge includes valves and a plurality of chambers for amplification.

Various embodiments are described herein for a recovery tool kit system including a recovery tool and an associated retrieval method for retrieving and storing an ingestible device.

An integrated testing device and fluid module are disclosed, as well as a method of manufacture. Fluid module contains a reservoir containing a test fluid, and a control vessel. The reservoir discharges test fluid into the control vessel, which discharges the test fluid in a controlled way to a test component.

Apparatus and methods are described for use with feces of a subject that are disposed within a toilet bowl. One or more light sensors receive light from the toilet bowl, while the feces are disposed within the toilet bowl. A computer processor detects a set of three or more spectral components that have a characteristic relationship with each other in a light spectrum of bile, by analyzing the received light, and detects a presence of bile within the feces, in response to detecting the set of three or more spectral components. The computer processor generates an output in response thereto. Other applications are also described.

An ingestible apparatus for collecting samples from a target area of a gastrointestinal (GI) tract of a subject and/or for delivering a health-related substance thereto. An example ingestible apparatus includes a housing defining a sample compartment, a stopper configured to seal an access port, and an actuation assembly connected to the stopper. The actuation assembly is movable between a first working position where the access port is open and a second working position where the access port is sealed with the stopper. The apparatus also includes a dissolvable block configured to prevent the actuation assembly from moving between the first and second working positions until the apparatus is within a target area of the GI tract. The actuation assembly is configured, in the second working position, to apply a linear force at an interface between the stopper and a sealing surface to seal the access port with the stopper.

The present invention is a disposable brief made of absorbent material with small amount of cellulose for good absorbance. The material has elasticity for comfort on the skin and stretch ability. The said invention was designed for full coverage to prevent any leakage from the anterior and posterior of the perinium. Velcro fastening on the lateral sides for easy removal and applying if needed. The said invention has a pocket in the front and back of the disposable material brief for the insertion of FDA approved Urine test strips for the anterior and FDA approved Guaiac paper that can be inserted in the posterior part of the brief. The brief was designed to be a funnel for testing material for early detection of urinary tract infections and gastrointestinal bleeding. Urine test strips and Guaiac paper purchased separately.

Fecal management methods and apparatuses (e.g., devices, systems, etc.) may apply one or more fecal removal cycles of suction and irrigation (and in some examples air) to actively remove fecal material. The apparatus may control the timing of delivery of the fecal removal cycles as well as the parameters of the applied suction, irrigation and/or air within and between fecal removal cycles.

Certain microorganism species in a composition for use in fecal microbiota transplantation (FMT), including fecal material obtained from an FMT donor, can affect the outcome of FMT treatment such as regulating the bodyweight and cholesterol level in FMT recipients. Thus, methods are provided for identifying subjects as suitable donor to optimize FMT outcome and for pretreating donors and/or recipients for optimized FMT outcome. Also provided are kits and compositions for improving FMT outcome, including for bodyweight and/or cholesterol reduction.